Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Biomed Res Int ; 2016: 7952891, 2016.
Article in English | MEDLINE | ID: mdl-27579322

ABSTRACT

Sucrase insufficiency has been observed in children with of functional bowel disorders (FBD) and symptoms of dietary carbohydrate intolerance may be indistinguishable from those of FBD. A two-phase (13)C-sucrose/(13)C-glucose breath test ((13)C-S/GBT) was used to assess sucrase activity because disaccharidase assays are seldom performed in adults. When (13)C-sucrose is hydrolyzed to liberate monosaccharides, oxidation to (13)CO2 is a proportional indicator of sucrase activity. Subsequently, (13)C-glucose oxidation rate was determined after a secondary substrate ingestion (superdose) to adjust for individual habitus effects (Phase II). (13)CO2 enrichment recovery ratio from (13)C-sucrose and secondary (13)C-glucose loads reflect the individualized sucrase activity [Coefficient of Glucose Oxidation for Sucrose (CGO-S)]. To determine if sucrase insufficiency could be a factor in FBD, (13)C-S/GBT was validated using subjects with known sucrase gene mutation status by comparing (13)CO2-breath enrichment with plasma (13)C-glucose enrichment. (13)C-S/GBT was used to assess sucrose digestion in FBD patients and asymptomatic controls. (13)CO2-breath enrichment correlated with the appearance of (13)C-sucrose-derived glucose in plasma (r (2) = 0.80). Mean, control group CGO-S-enrichment outcomes were 1.01 at 60', 0.92 at 75', and 0.96 at mean 60'-75' with normal CGO-S defined as >0.85 (95% C.I.). In contrast, FBD patients demonstrated lower CGO-S values of 0.77 at 60', 0.77 at 75', and 0.76 at mean 60'-75' (Chi Square: 6.55; p < 0.01), which points to sucrose maldigestion as a cause of FBD.


Subject(s)
Breath Tests/methods , Carbohydrate Metabolism, Inborn Errors/diagnosis , Glucose/analysis , Malabsorption Syndromes/diagnosis , Sucrose/analysis , Adult , Biomarkers/analysis , Carbohydrate Metabolism, Inborn Errors/diagnostic imaging , Carbohydrate Metabolism, Inborn Errors/metabolism , Carbon Isotopes/analysis , Female , Glucose/metabolism , Humans , Malabsorption Syndromes/metabolism , Male , Radiopharmaceuticals , Reproducibility of Results , Sensitivity and Specificity , Sucrose/metabolism
2.
Am Surg ; 78(4): 456-67, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22472405

ABSTRACT

Liver resection is considered the therapeutic gold standard for primary and metastatic liver neoplasms. The reduction of postoperative complications and mortality has resulted in a more aggressive approach to hepatic malignancies. For the most part, results of liver surgery have been published by highly experienced institutions, but the observations of highly specialized units results may not reflect the current status of hepatic surgery, underestimating mortality and complications. The objective of this study is to evaluate morbidity and mortality as a result of liver resection for primary and metastatic lesions, analyzing a large number of studies with a meta-analytic process taking into account the overdispersion of data. An extensive literature search has been conducted, and 148 papers published between January 2000 and April 2008, including a total of 36,629 patients from both high-volume and low volume institutions, were included in the meta-analysis. A beta binomial model was used to provide a robust estimate of the summary event rate by pooling overdispersion binomial data from different studies. Overall morbidity and mortality after liver surgery were 29.32 per cent and 3.15 per cent, respectively. Significantly higher postoperative mortality was observed after liver resection for hepatocellular carcinomas and primary hepatic tumors. The application of a beta binomial model to correct for overdispersion of liver surgery data showed significantly higher postoperative mortality rates in patients with hepatocellular carcinomas or primary hepatic tumors after liver resection.


Subject(s)
Carcinoma, Hepatocellular/surgery , Hepatectomy/mortality , Liver Neoplasms/surgery , Carcinoma, Hepatocellular/mortality , Humans , Liver Neoplasms/mortality , Models, Statistical , Postoperative Complications , Treatment Outcome
4.
Am Surg ; 77(3): 257-69, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21375833

ABSTRACT

Postoperative pancreatic fistula (POPF) is the most frequent complication after pancreaticoduodenectomy, results in increased morbidity and mortality, and adversely affects length of stay and costs. Reported rates of postoperative pancreatic fistula vary from 0 per cent up to more than 30 per cent. Plenty of randomized trails and meta-analysis were published to analyze the ideal procedure, technique of anastomosis, and perioperative management of patients undergoing pancreaticoduodenectomy; however, results are often discordant and clear evidence on the ideal management and surgical technique to reduce POPF rate is not yet provided. This collective review examined the current evidence about risk factors contributing to postoperative pancreatic fistula and delineates methods of diagnosis and treatment of this universally dreaded complication.


Subject(s)
Pancreatic Fistula/etiology , Pancreaticoduodenectomy , Postoperative Complications , Female , Humans , Male , Pancreatic Fistula/diagnosis , Pancreatic Fistula/therapy , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...